Interacting appetite-regulating pathways in the hypothalamic regulation of body weight

Endocrine Reviews

Volumn 20, Issue 1, 1999, Pages 68-100

  Kalra, Satya P ^a   Dube, Michael G ^a   Pu, Shuye ^a   Xu, Bin ^a   Horvath, Tamas L ^b   Kalra, Pushpa S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMPHETAMINE; APPETITE STIMULANT; COCAINE; GALANIN; GLUCAGON LIKE PEPTIDE 1; GLUTAMIC ACID; INSULIN; LEPTIN; MELANIN CONCENTRATING HORMONE; MELANOCORTIN; NEUROTENSIN; SEROTONIN;

ANOREXIA; ARCUATE NUCLEUS; BINDING SITE; BODY WEIGHT; CIRCADIAN RHYTHM; FOOD INTAKE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPHAGIA; NEUROANATOMY; OBESITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033038418     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.20.1.68     Document Type: Review

References (412)

1. 1. Kalra SP 1997 Appetite and body weight regulation: is it all in the brain? Neuron 19:227-230
2. 2. Stunkard AJ 1996 Current views on obesity. Am J Med 100:230-236
3. 3. Bray GA, Fisher J, York DA 1990 Neuroendocrine control of the development of obesity: understanding gained from studies of experimental animals. Front Neuroendocrinol 11:128-181
4. 4. Wadden TA 1993 The treatment of obesity: an overview. In: Stunkard AJ, Wadden TA (eds) Obesity Theory and Therapy. Raven Press, New York, pp. 197-217
5. 5. Perri MG, Nezu AM 1993 Preventing relapse following treatment of obesity. In: Stunkard AJ, Wadden TA (eds) Obesity Theory and Therapy. Raven Press, New York, pp. 287-299
6. 6. Bray GA 1996 Mechanism for development of genetic, hypothalamic and dietary obesity. In: Bray GA, Ryan DH (eds) Molecular and Genetic Aspects of Obesity. LSU Press, Baton Rouge, LA, pp. 2-66
7. 7. Stewart-Agras W, Kraemer HC 1984 The treatment of anorexia nervosa: do different treatments have different outcomes? In: Stunkard AJ, Stellar E (eds) Eating and Its Disorders. Association for Research in Nervous System and Mental Disease. Raven Press, New York, vol. 62:193-207
8. 8. Crisp AH 1984 The psychopathology of anorexia nervosa: getting the heat out of the system. In: Stunkard AJ, Stellar E (eds) Eating and its Disorders. Association for Research in Nervous System and Mental Disease. Raven Press, New York, vol. 62:209-234
9. 9. Moldawer LL, Lowry SF, Ceranii A 1988 Cachectin: its impact on metabolism and nutritional status. Annu Rev Nutr 8:585-609
10. 10. Plata-Salamań CR 1991 Immunoregulators in the nervous system. Neurosci Biobehav Rev 15:185-215
11. 11. Grunfeld C, Feingold K 1992 Metabolic disturbances and wasting in the acquired immuno-deficiency syndrome. N Engl J Med 327: 329-337
12. 12. Kalra SP, Sahu A, Dube MG, Bonavera JJ, Kalra PS 1996 Neuropeptide Y and its neural connections in the etiology of obesity and associated neuroendocrine and behavioral disorders. In: Bray GA, Ryan DH (eds) Molecular and Genetic Aspects of Obesity. LSU Press, Baton Rouge, LA, vol. 5:219-232
13. 13. Morely JE 1987 Neuropeptide regulation of appetite and weight. Endocr Rev 8:256-287
14. 14. Motta M 1991 Brain Endocrinology. Raven Press, New York, pp. 1-483
15. 15. Kalra SP, Kalra PS 1996 Nutritional infertility: the role of the interconnected hypothalamic (γ-galanin-opioid network. Front Neuroendocrinol 17:371-401
16. 16. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Freidman J 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432
17. 17. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chaib BT, Rabanowitz D, Lallone RL, Burley SK, Friedman JM 1995 Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546
18. 18. Kalra PS, Dube MG, Xu B, Kalra SP, Increased neuropeptide Y (NPY)-receptor sensitivity may underlie hyperphagia and obesity: a novel mechanism. Program of the Annual Conference of the North American Association for the Study of Obesity, Breckenridge, CO, 1996
19. 1 receptor mRNA is upregulated in association with transient hyperphagia and body weight gain: evidence for a hypothalamic site for concurrent development of leptin resistance. J Neuroendocrinol 10:43-49
20. 20. Hökfelt T, Füxe K, Pernow B 1986 Coexistence of neuronal messengers: a new principle in chemical neurotransmission. Progr Brain Res 68:1-411
21. 21. Everitt BJ, Hökfelt T 1989 The coexistence of neuropeptide Y with other peptides and amines in the central nervous system. In: Mutt V, Füxe K, Hökfelt T, Lundberg J (eds) Neuropeptide Y. Raven Press, New York pp 61-72
22. 22. Holets VR, Hökfelt T, Rökaeus Å, Terenius L, Goldstein M 1988 Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase, or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus. Neuroscience 24:893-906
23. 23. Kalra SP, Horvath T, Naftolin F, Xu B, Pu S, Kalra PS 1997 The interactive language of the hypothalamus for the gonadotropin releasing hormone (GNRH) system. J Neuroendocrinol 9:569-576
24. 24. Brobeck JR 1946 Mechanism of the development of obesity in animals with hypothalamic lesions. Physiol Rev 26:541-559
25. 25. Anand BK, Brobeck JR 1951 Hypothalamic control of food intake in rats and cats. Yale J Biol Med 24:123-146
26. 26. Powley TL, Opsahl CH, Cox JE, Weingarten HP 1980 The role of the hypothalamus in energy homeostasis. In: Morgane PJ, Panksepp J (eds) Handbook of the Hypothalamus. Part A: Behavioral Studies of the Hypothalamus. Marcel Dekker, Inc., New York, vol 3:211-298
27. 27. Luiten PG, ter Horst GJ, Steffens AB 1987 The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism. Prog Neurobiol 28:1-54
28. 28. Sclafani A, Kirchgessner A 1986 The role of the medial hypothalamus in the control of food intake: an update. In: Ritter RC, Ritter S, Barnes CD (eds) Feeding Behavior. Academic Press, New York, pp 27-66
29. 29. Bray GA 1984 Hypothalamic and genetic obesity: an appraisal of the autonomic hypothesis and the endocrine hypothesis. J Obes 8[Suppl 1]:119-137
30. 30. Sclafani A 1971 Neural pathways involved in the ventromedial hypothalamic lesion syndrome in the rat. J Comp Physiol Psychol 77:70-96
31. 31. Kalra SP, Kalra PS 1990 Neuropeptide Y: a novel peptidergic signal for the control of feeding behavior. In: Pfaff DW, Ganten D (eds) Current Topics in Neuroendocrinology. Springer-Verlag, Berlin, vol 10:192-197
32. 32. Leibowitz SF 1989 Hypothalamic neuropeptide Y, galanin, and amines. Concepts of coexistence in relation to feeding behavior. Ann NY Acad Sci 575:221-233
33. 33. Horvath TL, Naftolin F, Leranth C, Sahu A, Kalra SP 1996 Morphological and pharmacological evidence for neuropeptide Y-galanin interaction in the rat hypothalamus. Endocrinology 137: 3069-3077
34. 34. Horvath TL, Naftolin F, Kalra SP, Leranth C 1992 Neuropeptide-Y innervation of β-endorphin-containing cells in the rat mediobasal hypothalamus: a light and electron microscopic double immuno-staining analysis. Endocrinology 131:2461-2467
35. 35. Horvath TL, Kalra SP, Naftolin F, Leranth C 1995 Morphological evidence for a galanin-opiate interaction in the rat mediobasal hypothalamus. J Neuroendocrinol 7:579-588
36. 36. Horvath TL, Bechmann I, Naftolin F, Kalra SP, Leranth C 1997 Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations. Brain Res 756:283-286
37. 37. Pu S, Jain M, Horvath TL, Diano S, Kalra SP, Co-existence of neuropeptide Y (NPY) and γ-aminobutyric acid (GABA) in the hypothalamus: interactive effects on feeding. Program of the 27th Annual Meeting of the Society for Neuroscience, New Orleans, LA, 1997, vol 23:1344 (Abstract)
38. 38. Pu S, Jain MR, Horvath TL, Diano S, Kalra PS, Kalra SP 1999 Interactions between neuropeptide Y and γ-aminobutyric acid in stimulation of feeding: a morphological and pharmacological analysis. Endocrinology 140:933-940
39. 39. Hahn TM, Breiniger JF, Baskin DG, Schwartz MW 1998 Coexpression of AgrP and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1:271-272
40. 40. Chen P, Li C, Haskell-Luevano C, Cone RD, Smith MS, 1998 Expression of agouti-related transcript (ART) and neuropeptide Y (NPY) in the hypothalamic arcuate nucleus of female rats during the estrous cycle. Annual Meeting of the Endocrine Society, New Orleans, LA, 1998 (Abstract P3-663), p 521
41. 41. Chronwall BM 1985 Anatomy and physiology of the neuroendocrine arcuate nucleus. Peptides 6 [Suppl 2]:-11
42. 42. Finley JC, Maderdrut JL, Petrusz P 1981 The immunocytochemical localization of enkephalin in the central nervous system of the rat. J Comp Neurol 198:541-565
43. 43. Finley JC, Lindstrom P, Petrusz P 1981 Immunocytochemical localization of beta-endorphin-containing neurons in the rat brain. Neuroendocrinology 33:28-42
44. 44. Khachaturian H, Lewis ME, Shafer MKH, Watson SJ 1985 Anatomy of CNS opioid system. Trends Neurosci 8:111-119
45. 45. Merchenthaler I, Lopez FJ, Negro-Vilar A 1993 Anatomy and physiology of central galanin-containing pathways. Prog Neurobiol 40:711-769
46. 46. Crawley JN 1995 Biological actions of galanin. Regul Pept 59:1-16
47. 47. Decavel C, van den Pol AN 1990 GABA: a dominant neurotransmitter in the hypothalamus. J Comp Neurol 302:1019-1037
48. 48. Meister B, Hökfelt T 1988 Peptide-and transmitter-containing neurons in the mediobasal hypothalamus and their relation to GABAergic systems: possible roles in control of prolactin and growth hormone secretion. Synapse 2:585-605
49. 49. van den Pol AN, Wuarin JP, Dudek FE 1990 Glutamate, the dominant excitatory transmitter in neuroendocrine regulation. Science 250:1276-1278
50. 50. van den Pol AN 1991 Glutamate and aspartate immunoreactivity in hypothalamic presynaptic axons. J Neurosci 11:2087-2101
51. 51. Smith AI, Funder JW 1988 Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev 9:159-179
52. 52. Eipper BA, Mains RE 1980 Structure and biosynthesis of pro-adrenocorticotropin/endorphin and related peptides. Endocr Rev 1:1-27
53. 53. Imura H, Kato Y, Nakai Y, Nakao K, Tanaka I, Jingami H, Koh T, Yoshimasa T, Tsukada T, Suda M, Nakao K, Jinganii H, Koh T, Yihimago T, Tseukada T, Suda M, Sakanooto M, Morii N, Takesheshi H, Tojo K, Sugawara A 1985 Endogenous opioids and related peptides: from molecular biology to clinical medicine. The Sir Henry Dale lecture for 1985. J Endocrinol 107:147-157
54. 54. Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R, Stark KL 1997 Hypothalamic expression of ART, a novel gene related to agouti, is upregulated in obese and diabetic mutant mice. Genes Dev 11:593-602
55. 55. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS 1997 Antagonism of central melanocortin receptors in in vitro and in vivo by agouti-related protein. Science 278:135-138
56. 56. Kalra PS, Norlin M, Kalra SP 1995 Neuropeptide Y stimulates beta-endorphin release in the basal hypothalamus: role of gonadal steroids. Brain Res 705:353-356
57. 57. Douglass J, McKinzie AA, Couceryo P 1995 PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 15:2471-2481
58. 58. Gautvik KM, de Lecea L, Gautvik VT, Danielson PE, Tranque P, Dopazo A, Bloom FE, Sutcliffe JG 1996 Overview of the most prevalent hypothalamus-specific mRNA, as identified by directional tag PCR subtraction. Proc Natl Acad Sci USA 93:8733-8738
59. 59. Koylu EO, Couceyro PR, Lambert PD, Ling NC, De Souza EB, Kuhar MJ 1997 Immunohistochemical localization of novel CART peptides in the rat hypothalamus, pituitary and adrenal gland. J Neuroendocrinol 9:823-833
60. 60. Lambert PD, Couceyro PR, McGirr KM, Dall Vechia SE, Smith Y, Kuhar MJ 1998 CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse 29:293-298
61. 61. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S 1998 Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393:72-76
62. 62. Kalra PS, Dube MG, Xu B, Farmerie WG, Kalra SP 1998 Evidence that dark-phase hyperphagia induced by neurotoxin 6-hydroxy-dopamine may be due to decreased leptin and increased NPY signaling. Physiol Behav 63:829-835
63. 63. Kalra PS, Dube MG, Xu B, Kalra SP 1997 Increased receptor sensitivity to neuropeptide Y in the hypothalamus may underlie transient hyperphagia and body weight gain. Regul Pept 72:121-130
64. 64. Kalra PS, Edwards TG, Dube MG 1999 Hypothalamic galanin is upregulated during hyperphagia. NY Acad Sci 863:432-434
65. 65. Jain MR, Dube MG, Kalra SP, Kalra PS 1998 Neuropeptide Y release in the paraventricular nucleus is decreased during transient hyperphagia induced by microinjection of colchicine into the ventromedial nucleus of rats. Neurosci Lett 256:21-24
66. 66. Pu S, Dube MG, Xu B, Kalra SP, Kalra PS, Microinjection of colchicine into the hypothalamic ventromedial nucleus upregulates galanin expression in association with transient hyperphagia. Program of the 28th Annual Meeting of the Society for Neuroscience, Los Angeles, CA, 1998, vol 24: 448 (Abstract 175.8)
67. 67. Pu S, Dube MG, Edwards TG, Kalra SP, Kalra PS 1999 Disruption of neural signaling within the hypothalamic ventromedial nucleus upregulates galanin gene expression in association with hyperphagia: an in situ analysis. Mol Brain Res, in press
68. 68. Pu S, Dube MG, Xu B, Kalra SP, Kalra PS, Induction of neuropeptide Y (NPY) gene expression in novel hypothalamic sites in association with transient hyperphagia and body weight gain. Program of the 80th Annual Meeting of The Endocrine Society, New Orleans, LA, 1998 (Abstract P3-236), p 435
69. 69. Shimizu N, Oomura Y, Plata-Salaman CR, Morimoto M 1987 Hyperphagia and obesity in rats with bilateral ibotenic acid-induced lesions of the ventromedial hypothalamic nuclei. Brain Res 416:153-156
70. 70. Stanley BG, Chin AS, Leibowitz SF 1985 Feeding and drinking elicited by central injection of neuropeptide Y: evidence for a hypothalamic site(s) of action. Brain Res Bull 14:521-524
71. 71. Kyrkouli SE, Stanley BG, Seirafi RD, Leibowitz SF 1990 Stimulation of feeding by galanin: anatomical localization and behavioral specificity of this peptide's effects in the brain. Peptides 11:995-1001
72. 72. Kyrkouli SE, Stanley BG, Leibowitz SF 1986 Galanin: stimulation of feeding induced by medial hypothalamic injection of this novel peptide. Eur J Pharmacol 122:159-160
73. 73. Schick RR, Samsami S, Zimmermann JP, Eberl T, Endres C, Schusdziarra V, Classen M 1993 Effect of galanin on food intake in rats: involvement of lateral and ventromedial hypothalamic sites. Am J Physiol 264:R355-R361
74. 74. Grandison L, Guidotti A 1977 Stimulation of food intake by muscimol and beta endorphin. Neuropharmacology 16:533-536
75. 75. Kelly J, Grossman SP 1980 GABA and hypothalamic feeding systems. Brain Res Bull 5:237-244
76. 76. Kelly J, Rothstein J, Grossman SP 1979 GABA and hypothalamic feeding systems. I. Topographic analysis of the effects of microinjections of muscimol. Physiol Behav 23:1123-1134
77. 77. Kelly J, Alheid GF, Newberg A, Grossman SP 1977 GABA stimulation and blockade in the hypothalamus and midbrain: effects on feeding and locomotor activity. Pharmacol Biochem Behav 7:537-541
78. 78. Satoh N, Ogawa Y, Katsuura G, Hayase M, Tsuji T, Imagawa K, Yoshimasa Y, Nishi S, Hosoda K, Nakao K 1997 The arcuate nucleus as a primary site of satiety effect of leptin in rats. Neurosci Lett 224:149-152
79. 79 Jacob RJ, Dziura J, Medwick MB, Leone P, Caprio S, During M, Shulman GI, Sherwin RS 1997 The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus. Diabetes 46: 150-152
80. 80. Ohata H, Suzuki K, Oki Y, Arai K, Shibasaki T, Urocortin in the ventromedial nucleus of the hypothalamus (VMH) inhibits feeding behavior in rats. Program of the 80th Annual Meeting of The Endocrine Society, New Orleans, LA, 1998 (Abstract OR22-2), p 95
81. 81. Bernardis LL, Bellinger LL 1987 The dorsomedial hypothalamic nucleus revisited: 1986 update. Brain Res 434:321-381
82. 82. Bellinger LL, Mendel VE, Bernardis LL, Castonguay TW 1986 Meal patterns of rats with dorsomedial hyopthalamic nuclei lesions or sham operations. Physiol Behav 36:693-698
83. 83. Moga M, Saper CB 1994 Neuropeptide-immunoreactive neurons projecting to the paraventricular hypothalamic nucleus in the rat. J Comp Neurol 346:137-150
84. 84. Thompson RH, Ganteras NS, Swanson LW 1996 Organization of projections from the dorsomedial nucleus of the hypothalamus: a PHA-L study in the rat. J Comp Neurol 376:143-173
85. 85. Bernardis LL, Bellinger LL 1996 The lateral hypothalamic area revisited: ingestive behavior. Neurosci Biobehav Rev 20:189-287
86. 86. Steffens AB 1975 Influence of reversible obesity on eating behavior, blood glucose, and insulin in the rat. Am J Physiol 281:1738-1744
87. 87. Steinbaum EA, Miller NE 1965 Obesity from eating elicited by daily stimulation of hypothalamus. Am J Physiol 208:1-5
88. 88. Elmquist JK, Ahima RS, Maratos-Flier E, Flier JS, Saper CB 1997 Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology 138:839-842
89. 89. Yokosuka M, Xu B, Pu S, Kalra SP, The magnocellular part of the paraventricular hypothalamic nucleus (PVN): a selective site for inhibition of NPY-induced food intake by leptin. Program of the 27th Annual Meeting Society for Neuroscience, New Orleans, LA, 1997, vol 23:1344 (Abstract)
90. 90. Yokosuka M, Xu B, Pu S, Kalra PS, Kalra SP 1998 Neural substrates for leptin and neuropeptide Y (NPY) interaction: hypothalamic sites associated with inhibition of NPY-induced food intake. Physiol Behav 64:331-338
91. 91. Sawchenko PE, Swanson LW 1983 The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat. J Comp Neurol 218:121-144
92. 92. Elmquist JK, Ahima RS, Elias CF, Flier JS, Saper CB 1998 Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc Natl Acad Sci USA 95:741-746
93. 93. Bai FL, Yamano M, Shiotani Y, Emson PC, Smith AD, Powell JF, Tohyama M 1985 An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res 331:172-175
94. 94. Sahu A, Kalra PS, Kalra SP 1988 Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides 9:83-86
95. 95. Kamegai J, Minami S, Sugihara H, Hasegawa O, Higuchi H, Wakabayashi I 1996 Growth hormone receptor gene is expressed in neuropeptide Y neurons in hypothalamic arcuate nucleus of rats. Endocrinology 137:2109-2112
96. 96. Chan YY, Steiner RA, Clifton DK 1996 Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat. Endocrinology 137:1319-1325
97. 97. Kesterson RA, Huszar D, Lynch CA, Simerly RB, Cone RD 1997 Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol Endocrinol 11:630-637
98. 98. Li C, Chen P, Smith MS 1998 Neuropeptide Y (NPY) neurons in the arcuate nucleus (ARH) and dorsomedial nucleus (DMH), areas activated during lactation, project to the paraventricular nucleus of the hypothalamus. Regul Pept 75-76:93-100
99. 99. Swanson LW, Sawchenko PE 1983 Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 6:269-324
100. 100. Dube MG, Kalra SP, Kalra PS, Food intake elicited by central administration of orexins: identification of hypothalamic sites of action. Program of the 28th Annual Meeting of the Society for Neuroscience, Los Angeles, CA, 1998, vol 24:448 (Abstract 175.8)
101. 101. Krahn DD, Gosnell BA, Levine AS, Morley JE 1988 Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res 443:63-69
102. 102. Monnikes H, Heymann-Monnikes I, Tache Y 1992 CRF in the paraventricular nucleus of the hypothalamus induces dose-related behavioral profile in rats. Brain Res 574:70-76
103. 103. Li BH, Xu B, Rowland NE, Kalra SP 1994 c-fos Expression in the rat brain following central administration of neuropeptide Y and effects of food consumption. Brain Res 665:277-284
104. 104. Xu B, Li BH, Rowland NE, Kalra SP 1995 Neuropeptide Y injection into the fourth cerebroventricle stimulates c-fos expression in the paraventricular nucleus and other nuclei in the forebrain: effect of food consumption. Brain Res 698:227-231
105. 105. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG 1996 Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98:1101-1106
106. 106. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS 1991 Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA 88:10931-10935
107. 107. Dube MG, Sahu A, Kalra PS, Kalra SP 1992 Neuropeptide Y release is elevated from the microdissected paraventricular nucleus of food-deprived rats: an in vitro study. Endocrinology 131:684-688
108. 108. Aravich FF, Sclafani A 1983 Paraventricular hypothalamic lesions and medial hypothalamic knife cuts produce similar hyperphagia syndromes. Behav Neurosci 97:970-983
109. 109. Weingarten HP, Chang PK, McDonald TJ 1985 Comparison of the metabolic and behavioral disturbances following paraventricular-and ventromedial-hypothalamic lesions. Brain Res Bull 14:551-559
110. 110. Tokunaga K, Fukushima M, Kemnitz JW, Bray GA 1986 Comparison of ventromedial and paraventricular lesions in rats that become obese. Am J Physiol 251:R1221-R1227
111. 111. Leibowitz SF 1978 Paraventricular nucleus: a primary site mediating adrenergic stimulation of feeding and drinking. Pharmacol Biochem Behav 8:163-175
112. 112. Stanley BG, Magdalin W, Seirafi A, Thomas WJ, Leibowitz SF 1993 The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s). Brain Res 604:304-317
113. 113. Stricker EM 1990 Handbook of Behavioral Neurobiology: Neurobiology of Food and Fluid Intake. Plenum Press, New York, vol 10:1-553
114. 114. Nagai K, Nishio T, Nakagawa H, Nakamura S, Fukuda Y 1978 Effect of bilateral lesions of the suprachiasmatic nuclei on the circadian rhythm of food-intake. Brain Res 142:384-389
115. 115. Van den Pol AN, Powley T 1979 A fine-grained anatomical analysis of the role of the rat suprachiasmatic nucleus in circadian rhythms of feeding and drinking. Brain Res 160:307-326
116. 116. Leon GR, Roth L 1977 Obesity: psychological causes, correlations, and speculations. Psychol Bull 84:117-139
117. 117. Jhanwar-Uniyal M, Beck B, Burlet C, Leibowitz SF 1990 Diurnal rhythm of neuropeptide Y-like immunoreactivity in the suprachiasmatic, arcuate and paraventricular nuclei and other hypothalamic sites. Brain Res 536:331-334
118. 118. Akabayashi A, Zaia CT, Koenig JI, Gabriel SM, Silva I, Leibowitz SF 1994 Diurnal rhythm of galanin-like immunoreactivity in the paraventricular and suprachiasmatic nuclei and other hypothalamic areas. Peptides 15:1437-1444
119. 119. Akabayashi A, Watanabe Y, Gabriel SM, Chae HJ, Leibowitz SF 1994 Hypothalamic galanin-like immunoreactivity and its gene expression in relation to circulating corticosterone. Brain Res Mol Brain Res 25:305-312
120. 120. Xu B, Kalra PS, Kalra SP, Food restriction upregulates hypothalamic NPY gene expression: loss of daily rhythmicity. Program of the 26th Annual Meeting of the Society for Neuroscience, Washington DC, 1996, vol 22:1685 (Abstract)
121. 121. Xu B, Kalra PS, Kalra SP, Food restriction abolishes the daily rhythm in gene expression of hypothalamic neuropeptide Y (NPY), galanin (GAL) and β-endorphin (POMC) and adipocyte leptin but not in leptin secretions. Program of the 80th Annual Meeting of The Endocrine Society, New Orleans, 1998 (Abstract P3-246), p 437
122. 122. Steiner RA, Kabigting E, Lent K, Clifton DK 1994 Diurnal rhythm in proopiomelanocortin mRNA in the arcuate nucleus of the male rat. J Neuroendocrinol 6:603-608
123. 123. Xu B, Kalra PS, Farmerie WG, Kalra SP, Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin and adipocyte leptin gene expression and secretion: effects of food-restriction. Endocrinology, in press
124. 124. Buijs RM 1996 The anatomical basis for the expression of circadian rhythms: the efferent projections of the suprachiasmatic nucleus. Prog Brain Res 111:229-240
125. 125. Watts AG, Swanson LW, Sanchez-Watts G 1987 Efferent projections of the suprachiasmatic nucleus. I. Studies using anterograde transport of Phaseolus vulgaris leucoagglutinin in the rat. J Comp Neurol 258:204-229
126. 126. Watts AG, Swanson LW 1987 Efferent projections of the suprachiasmatic nucleus. II. Studies using retrograde transport of fluorescent dyes and simultaneous peptide immunohistochemistry in the rat. J Comp Neurol 258:230-252
127. 127. Vrang N, Larsen PJ, Mikkelsen JD 1995 Direct projection from the suprachiasmatic nucleus to hypophysiotrophic corticotropin-releasing factor immunoreactive cells in the paraventricular nucleus of the hypothalamus demonstrated by means of Phaseolus vulgaris-leucoagglutinin tract tracing. Brain Res 684:61-69
128. 128. Hermes ML, Buijs RM, Renaud LP 1996 Electrophysiology of suprachiasmatic nucleus projections to hypothalamic paraventricular nucleus neurons. Prog Brain Res 111:241-252
129. 129. Luiten PG, ter Horst GJ, Steffens AB 1987 The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism. Prog Neurobiol 28:1-54
130. 130. Horvath TL 1997 Suprachiasmatic efferents avoid phenestrated capillaries but innervate neuroendocrine cells, including those producing dopamine. Endocrinology 138:1312-1320
131. 131. Akabayashi A, Levin N, Paez X, Alexander JT, Leibowitz SF 1994 Hypothalamic neuropeptide Y and its gene expression: relation to light/dark cycle and circulating corticosterone. Mol Cell Neurosci 5:210-218
132. 132. Buijs RM, Markman M, Nunes-Cardoso B, Hou YX, Shinn S 1993 Projections of the suprachiasmatic nucleus to stress-related areas in the rat hypothalamus: a light and electron microscopic study. J Comp Neurol 335:42-54
133. 133. Roland BL, Sawchenko PE 1993 Local origins of some GABAergic projections to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Comp Neurol 332:123-143
134. 134. Levin MC, Sawchenko PE, Howe PR, Bloom SR, Polak JM 1987 Organization of galanin-immunoreactive inputs to the paraventricular nucleus with special reference to their relationship to catecholaminergic afferents. J Comp Neurol 261:562-582
135. 135. ter Horst GJ, Luiten PG 1986 The projections of the dorsomedial hypothalamic nucleus in the rat. Brain Res Bull 16:231-248
136. 136. Clark JT, Kalra PS, Crowley WR, Kalra SP 1984 Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115:427-429
137. 137. Clark JT, Sahu A, Kalra PS, Balasubramaniam A, Kalra SP 1987 Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparisons with human NPY ([Met17]NPY), NPY analog ([norLeu4]NPY) and peptide YY. Regul Pept 17:31-39
138. 138. Tatemoto K 1982 Neuropeptide Y: complete ammo acid sequence of the brain peptide. Proc Natl Acad Sci USA 79:5485-5489
139. 139. Kalra SP, Kalra PS 1996 Is neuropeptide Y a naturally occurring appetite transducer? Curr Opin Endocrinol Diab 3:157-163
140. 140. Chronwall BB 1988 Anatomical distribution of NPY and NPY messenger RNA in the brain. In: Mutt V, Füxe K, Hökfelt T, Lundberg JD (eds) Neuropeptide Y. Raven Press, New York, pp. 51-60
141. 141. Sahu A, Dube MG, Kalra SP, Kalra PS 1988 Bilateral neural transection at the level of mesencephalon increase food intake and reduce latency to onset of feeding in response to neuropeptide Y. Peptides 9:1269-1273
142. 142. Sahu A, Kalra SP, Crowley WR, Kalra PS 1988 Evidence that NPY-containing neurons in the brain stem project into selected hypothalamic nuclei: implication in feeding behavior. Brain Res 457:376-378
143. 143. Clark JT, Gist RS, Kalra SP, Kalra PS 1988 Alpha 2-adrenoceptor blockade attenuates feeding behavior induced by neuropeptide Y and epinephrine. Physiol Behav 43:417-422
144. 144. Baker RA, Herkenham M 1995 Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat. J Comp Neurol 358:518-530
145. 145. Dube MG, Sahu A, Phelps CP, Kalra PS, Kalra SP 1992 Neuropeptide Y (NPY) concentration is decreased in the paraventricular nucleus (PVN) of rats exhibiting excessive weight gain produced by ventromedial hypothalamic lesions. Program of the 22nd Annual Meeting of the Society for Neuroscience, Anaheim, CA, 1992, vol 18:937 (Abstract)
146. 146. Dube MG, Xu B, Kalra PS, Sninsky CA, Kalra SP 1999 Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats. Brain Res 816:38-46
147. 147. Dumont T, Jacques D, St. Pierre J-A, Quirion R 1997 Neuropeptide Y receptor types in the mammalian brain: species differences and status in the human central nervous system. In: Grundermar L, Bloom S (eds) Neuropeptide Y and Drug Development. Academic Press, New York, pp 57-86
148. 1)-receptor mRNA-expressing cells in the rat arcuate nucleus. Neurosci Lett 148:195-198
149. 1 mRNA in forebrain areas of the rat central nervous system. Eur J Neurosci 5:1622-1637
150. 150. Daniels AJ, Matthews JE, Slepetis RJ, Jansen M, Viveros OH, Tadepalli A, Harrington W, Heyer D, Landavazo A, Leban JJ, Spaltenstein A 1995 High-affinity neruopeptide Y receptor antagonists. Proc Natl Acad Sci USA 92:9067-9071
151. 151. Matthews J, Jansen M, Lyarly D, Cox R, Chen W-J, Koller K, Daniels AJ 1997 Pharmacological characterization and selectivity of the NPY antagonist GR231118 (1229U91) for different NPY receptors. Regul Pept 72:113-119
152. 1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake. Endocrinology 137:3177-3182
153. 1 receptors in the hypothalamus underlie NPY hypothermia and feeding in rats. Proc R Soc Lond B Biol Sci 263:881-886
154. 1 antagonist BIBP3226 and 1229U91 on NPY-induced feeding in CD-1 mice. Program of the 27th Annual Meeting of the Society for Neuroscience, New Orleans, LA, 1997, vol 23:1766 (Abstract)
155. 155. Iyenger S, Simmons RMA, Li DL, Cantrell B, Kallman MJ, Bruns RF, Calligaro DO, Hipskind PA, Zimmerman DM, Gehlert DR, Effect of new structurally novel neuropeptide Y antagonists on NPY-induced feeding. Program of the 27th Annual Meeting of the Society for Neuroscience, New Orleans, LA, 1997, vol 23:1766 (Abstract)
156. 156. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL 1996 A receptor subtype involved in neuropeptide Y-induced food intake. Nature 382:168-171
157. 157. Hu Y, Bloomquist BT, Cornfield LJ, DeCarr LB, Flores-Riveros JR, Friedman L, Jiang P, Lewis-Higgins L, Sadlowski Y, Schaefer J, Velazquez N, McCaleb ML 1996 Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J Biol Chem 271:26315-26319
158. 5 receptor antisense oligodeoxynucleotides. Diabetes 46:1792-1798
159. 5 receptor subtype. Program of the 27th Annual Meeting of the Society for Neuroscience, New Orleans, LA, 1997, vol 23:575 (Abstract)
160. 160. Widdowson PS 1997 Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 "feeding" receptor. Brain Res 758:17-25
161. 161. Dumont Y, Fournier A, Quirion R 1998 Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain. J Neurosci 18:5565-5574
162. 162. Füxe K, Agnati LH (eds) 1991 Volume Transmission in the Brain: New Mechanism for Neural Transmission, vol 1: Advances in neuroscience. Raven Press, New York
163. 163. Füxe K, Agnati L, Aguirre J, Bjelke B, Tinner E, Merlo P, Eneroth P 1991 On the existence of volume transmission in the central neuropeptide Y receptor mismatch and on biological effects of neuropeptide Y fragments. In: Füxe K, Agnati LF (eds) Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission. Raven Press, New York, vol. 1:105-130
164. 164. Yokusuka M, Xu B, Kalra PS, Kalra SP, Neuropeptide Y target neurons for stimulation of feeding reside in the magnocellular paraventricular nucleus. Program of the 28th Annual Meeting of the Society for Neuroscience. Los Angeles, CA, 1998, vol 24:11 (Abstract 11.2)
165. 165. Meister B, Ceccatelli S, Hökfelt T, Anden NE, Anden M, Theodorsson E 1989 Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions. Exp Brain Res 76:343-368
166. 2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin-and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 66:393-408
167. 1 receptor-like immunoreactivity exists in a subpopulation of beta-endorphin immunoreactive nerve cells in the arcuate nucleus: a double immunolabeling analysis in the rat. Neurosci Lett 225:49-52
168. 168. Rhim H, Kinney GA, Emmerson PJ, Miller RJ 1997 Regulation of neurotransmission in the arcuate nucleus of the rat by different neuropeptide Y receptors. J Neurosci 17:2980-2989
169. 169. Clark JT, Kalra PS, Kalra SP 1985 Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Endocrinology 117: 2435-2442
170. 170. Kalra SP, Dube MG, Kalra PS 1988 Continuous intraventricular infusion of neuropeptide Y evokes episodic food intake in satiated female rats: effects of adrenalectomy and cholecystokinin. Peptides 9:723-728
171. 171. Kalra SP, Clark JT, Sahu A, Dube MG, Kalra PS 1988 Control of feeding and sexual behaviors by neuropeptide Y: physiological implications. Synapse 2:254-257
172. 172. Dube MG, Xu B, Crowley WR, Kalra PS, Kalra SP 1994 Evidence that neuropeptide Y is a physiological signal for normal food intake. Brain Res 646:341-344
173. 173. Xu B, Kalra PS, Moldawer LL, Kalra SP 1998 Increased appetite augments hypothalamic NPY Y1 receptor gene expression: effects of anorexigenic ciliary neurotropic factor. Regul Pept 75-76:391-395
174. 174. Dryden S, Pickavance L, Frankish HM, Williams G 1995 Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res 690:185-188
175. 175. Sancora G, Kershaw M, Finkelstein JA, White JD 1990 Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 127:730-737
176. 176. Wilding JP, Gilbey SG, Bailey CJ, Batt RA, Williams G, Ghatei MA, Bloom SR 1993 Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 132: 1939-1944
177. 177. Williams G, Steel JH, Cardoso H, Ghatei MA, Lee YC, Gill JS, Burrin JM, Polak JM, Bloom SR 1988 Increased hypothalamic neuropeptide Y concentrations in diabetic rat. Diabetes 37:763-772
178. 178. Williams G, Gill JS, Lee YC, Cardoso HM, Okpere BE, Bloom SR 1989 Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozocin-induced diabetic rats. Diabetes 38: 321-327
179. 179. Sahu A, Sninsky CA, Kalra PS, Kalra SP 1990 Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. Endocrinology 126:192-198
180. 180. Sahu A, Sninsky CA, Phelps CP, Dube MG, Kalra PS, Kalra SP 1992 Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats. Endocrinology 131:2979-2985
181. 181. Sahu A, Sninsky CA, Kalra SP 1997 Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes. Brain Res 755:339-342
182. 182. Smith MS 1993 Lactation alters neuropeptide-Y and proopiomelanocortin gene expression in the arcuate nucleus of the rat. Endocrinology 133:1258-1265
183. 1 receptor. Nat Med 4:722-726
184. 184. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS 1991 Structure-function analysis of stimulation of food intake by neuropeptide Y: effects of receptor agonists. Physiol Behav 50:5-9
185. 5 neuropeptide Y receptor in feeding and obesity. Nat Med 4:718-721
186. 186. Haynes AC, Arch JR, Wilson S, McClue S, Buckingham RE 1998 Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor? Regul Pept 75-76:355-361
187. 187. Wyss P, Stricker-Krongrad A, Brunner L, Miller J, Crossthwaite A, Whitebread S, Criscione L 1998 The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes. Regul Pept 75-76: 363-371
188. 188. Kanatani A, Ito J, Ishihara A, Iwaasa H, Fukuroda T, Fukami T, MacNeil DJ, Van der Ploeg LH, Ihara M 1998 NPY-induced feeding involves the action of a Y1-like receptor in rodents. Regul Pept 75-76:409-415
189. 189. Sahu A, White JD, Kalra PS, Kalra SP 1992 Hypothalamic neuropeptide Y gene expression in rats on scheduled feeding regimen. Mol Brain Res 15:15-18
190. 190. Guy J, Pelletier G, Bosler O 1988 Serotonin innervation of neuropeptide Y-containing neurons in the rat arcuate nucleus. Neurosci Lett 85:9-13
191. 191. Dube MG, Sahu A, Phelps CP, Kalra PS, Kalra SP 1992 Effect of d-fenfluramine on neuropeptide Y concentration and release in the paraventricular nucleus of food-deprived rats. Brain Res Bull 29: 865-869
192. 192. Rogers P, McKibbin PE, Williams G 1991 Acute fenfluramine administration reduces neuropeptide Y concentrations in specific hypothalamic regions of the rat: possible implications for the anorectic effect of fenfluramine. Peptides 12:251-255
193. 193. Dryden S, Frankish HM, Wang Q, Pickavance L, Williams G 1996 The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats. Neuroscience 72:557-566
194. 194. Sar M, Sahu A, Crowley WR, Kalra SP 1990 Localization of neuropeptide-Y immunoreactivity in estradiol-concentrating cells in the hypothalamus. Endocrinology 127:2752-2756
195. 195. Sahu A, Phelps CP, White JD, Crowley WR, Kalra SP, Kalra PS 1992 Steroidal regulation of hypothalamic neuropeptide Y release and gene expression. Endocrinology 130:3331-3336
196. 196. Sahu A, Crowley WR, Kalra SP 1994 Hypothalamic neuropeptide-Y gene expression increases before the onset of the ovarian steroid-induced luteinizing hormone surge. Endocrinology 134: 1018-1022
197. 197 Hisano S, Kagotani Y, Tsuruo Y, Daikoku S, Chihara K, Whitnall MH 1988 Localization of glucocorticoid receptor in neuropeptide Y-containing neurons in the arcuate nucleus of the rat hypothalamus. Neurosci Lett 95:13-18
198. 198. Harfstrand A, Cintra A, Fuxe K, Aronsson M, Wikstrom AC, Okret S, Gustafsson JA, Agnati LF 1989 Regional differences in glucocorticoid receptor immunoreactivity among neuropeptide Y immunoreactive neurons of the rat brain. Acta Physiol Scand 135: 3-9
199. 1-receptor mRNA levels in the arcuate nucleus of the rat. J Neuroendocrinol 6:153-159
200. 200. Nicolaidis S 1978 Neural mechanism of energy equilibrium. J Annu Diabetol Hotel Dieu 1:15:153-156
201. 201. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte Jr D 1992 Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 13:387-414
202. 202. Sahu A, Kalra SP, Crowley WR, Kalra PS 1989 Testosterone raises neuropeptide Y concentrations in selected hypothalamic sites and in vitro release from the medial basal hypothalamus of castrated male rats. Endocrinology 124:410-414
203. 203. Sahu A, Crowley WR, Kalra SP 1995 Evidence that hypothalamic neuropeptide Y gene expression increases before the onset of the preovulatory LH surge. J Neuroendocrinol 7:291-296
204. 204. Bonavera JJ, Dube MG, Kalra PS, Kalra SP 1994 Anorectic effects of estrogen may be mediated by decreased neuropeptide-Y release in the hypothalamic paraventricular nucleus. Endocrinology 134: 2367-2370
205. 205. Baskin DG, Norwood BJ, Schwartz MW, Koerker DJ 1995 Estradiol inhibits the increase of hypothalamic neuropeptide Y messenger ribonucleic acid expression induced by weight loss in ovariectomized rats. Endocrinology 136:5547-5554
206. 206. Liposits Z, Sievers L, Paull WK 1988 Neuropeptide-Y and ACTH-immunoreactive innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamus of the rat. An immunocytochemical analysis at the light and electron microscopic levels. Histochemistry 88:227-234
207. 207. Wahlestedt C, Skagerberg G, Ekman R, Heilig M, Sundler F, Hakanson R 1987 Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res 417:33-38
208. 208. Wilding JP, Gilbey SG, Lambert PD, Ghatei MA, Bloom SR 1993 Increases in neuropeptide Y content and gene expression in the hypothalamus of rats treated with dexamethasone are prevented by insulin. Neuroendocrinology 57:581-587
209. 209. White BD, Dean RG, Martin RJ 1990 Adrenalectomy decreases neuropeptide Y mRNA levels in the arcuate nucleus. Brain Res Bull 25:711-715
210. 210. Akabayashi A, Watanabe Y, Wahlestedt C, McEwen BS, Paez X, Leibowitz SF 1994 Hypothalamic neuropeptide Y, its gene expression and receptor activity: relation to circulating corticosterone in adrenalectomized rats. Brain Res 665:201-212
211. 211. Dallman MF, Strack AM, Akana SF, Bradbury MJ, Hanson ES, Scribner KA, Smith M 1993 Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol 14:303-347
212. 212. Ponsalle P, Srivastva LS, Uht RN, White JD 1992 Glucocorticoids are required for food deprivation-induced increases in hypothalamic neuropeptide Y expression. J Neuroendocrinol 4:585-591
213. 213. Hanson ES Levin N, Dallman MF 1997 Elevated corticosterone is not required for the rapid induction of neuropeptide Y gene expression by an overnight fast. Endocrinology 138:1041-1047
214. 214. White JD, Olchovsky D, Kershaw M, Berelowitz M 1990 Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats. Endocrinology 126: 765-772
215. 215. Cusin I, Dryden S, Wang Q, Rohner-Jeanrenaud F, Jeanrenaud B, Williams G 1995 Effect of sustained physiological hyperinsulinaemia on hypothalamic neuropeptide Y and NPY mRNA levels in the rat. J Neuroendocrinol 7:193-197
216. 216 Sahu A, Dube MG, Phelps CP, Sninsky CA, Kalra PS, Kalra SP 1995 Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis. Endocrinology 136:5718-5724
217. 217. Porter JP, Bokil HS 1997 Effect of intracerebroventricular and intravenous insulin on FOS-immunoreactivity in the rat brain. Neurosci Lett 224:161-164
218. 218. Kalra SP, Xu B, Dube MG, Moldawer LL, Martin D, Kalra PS 1998 Leptin and ciliary neurotropic factor (CNTF) inhibit fasting-induced suppression of luteinizing hormone release in rats: role of neuropeptide Y. Neurosci Lett 240:45-49
219. 219. Xu B, Dube MG, Kalra PS, Farmerie WG, Kaibara A, Moldawer LL, Martin D, Kalra SP 1998 Anorectic effects of the cytokine, ciliary neurotropic factor (CNTF), are mediated by hypothalamic neuropeptide Y (NPY): comparison with leprin. Endocrinology 139:466-473
220. 220. Spiegelman BM, Flier JS 1996 Adipogenesis and obesity: rounding out the big picture. Cell 87:377-389
221. 221. Bray G, Bouchard C 1997 Genetics of human obesity: research directions. FASEB J 11:937-945
222. 222. Sclafani A 1984 Animal models of obesity: classification and characterization. Int J Obes 8:491-508
223. 223. Chua Jr SC, Brown AW, Kim J, Hennessey KL, Leibel RL, Hirsch J 1991 Food deprivation and hypothalamic neuropeptide gene expression: effects of strain background and the diabetes mutation. Mol Brain Res 11:291-299
224. 224. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, Mackellar W, Rosteck Jr PR, Schnener B, Smith D, Tinsley FC, Zhang X-Y, Heiman M 1995 The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377:530-532
225. 225. Wang Q, Bing C, Al-Barazanji K, Mossakowaska DE, Wang XM, McBay DL, Neville WA, Taddayon M, Pickavance L, Dryden S, Thomas ME, McHale MT, Gloyer IS, Wilson S, Buckingham R, Arch JR, Trayhurn P, Williams G 1997 Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes 46:335-341
226. 226. Frederich RC, Lollmann B, Hamann A, Napolitano-Rosen A, Kahn BB, Lowell BB, Flier JS 1995 Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 96:1658-1663
227. 227. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV 1996 Leptin: the tale of an obesity gene. Diabetes 45:1455-1462
228. 228. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P 1995 Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-549
229. 229. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-543
230. 230. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rakinowitz D, Lallone RL, Burley SK, Friedman JM 1995 Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546
231. 231. Coleman DL 1978 Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14:141-148
232. 232. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM 1996 Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635
233. 233. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP 1996 Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491-495
234. 234. Maffei M, Fei H, Lee GH, Dani C, Leroy P, Zhang Y, Proenca R, Negrel R, Ailhaud G, Friedman JM 1995 Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc Natl Acad Sci USA 92:6957-6960
235. 235. White BD, Martin RJ 1997 Evidence for a central mechanism of obesity in the Zucker rat: role of neuropeptide Y and leptin. Proc Soc Exp Biol Med 214:222-232
236. 236. Murakami T, Shima K 1995 Cloning of rat obese cDNA and its expression in obese rats. Biochem Biophys Res Commun 209:944-952
237. 237. Frankish HM, Dryden S, Hopkins D, Wang Q, Williams G 1995 Neuropeptide Y, the hypothalamus, and diabetes: insights into the central control of metabolism. Peptides 16:757-771
238. 238. Hoebel BG 1984 Neurotransmitters in the control of feeding and its rewards: monoamines, opiates and brain-gut peptides. Res Publ Assoc Res Nerv Ment Dis 62:15-38
239. 239. Dube MG, Kalra PS, Crowley WR, Kalra SP 1995 Evidence of a physiological role for neuropeptide Y in ventromedial hypothalamic lesion-induced hyperphagia. Brain Res 690:275-278
240. 240. Avrith D, Mogenson GJ 1978 Reversible hyperphagia and obesity following intracerebral microinjections of colchicine into the ventromedial hypothalamus of the rat. Brain Res 153:99-107
241. 241. Stricker-Krongrad A, Beck B, Burlet C 1996 Enhanced feeding response to neuropeptide Y in hypothalamic neuropeptide Y-depleted rats. Eur J Pharmacol 295:27-34
242. 242. Bergen HT, Mobbs CV 1996 Ventromedial hypothalamic lesions produced by gold thioglucose do not impair induction of NPY mRNA in the arcuate nucleus by fasting. Brain Res 707:266-271
243. 243. Ahlskog JE, Hoebel BG 1973 Overeating and obesity from damage to a noradrenergic system in the rat brain. Science 182:166-169
244. 244. Kyrkouli SE, Stanley BG, Hutchinson R, Seirafi RD, Leibowitz SF 1990 Peptide-amine interactions in the hypothalamic paraventricular nucleus: analysis of galanin and neuropeptide Y in relation to feeding. Brain Res 521:185-191
245. 245. Kyrkouli SE, Stanley BG, Leibowitz SF 1992 Differential effects of galanin and neuropeptide Y on extracellular norepinephrine levels in the paraventricular hypothalamic nucleus of the rat: a microdialysis study. Life Sci 51:203-210
246. 246. Dube MG, Horvath TL, Leranth C, Kalra PS, Kalra SP 1994 Naloxone reduces the feeding evoked by intracerebroventricular galanin injection. Physiol Behav 56:811-813
247. 247. Koegler FH, Ritter S 1997 Aqueduct occlusion does not impair feeding induced by either third or fourth ventricle galanin injection. Obes Res 5:262-267
248. 248. Corwin RL, Robinson JK, Crawley JN 1993 Galanin antagonists block galanin-induced feeding in the hypothalamus and amygdala of the rat. Eur J Neurosci 5:1528-1533
249. 249. Corwin RL, Rowe PM, Crawley JN 1995 Galanin and the galanin antagonist M40 do not change fat intake in a fat-chow choice paradigm in rats. Am J Physiol 269:R511-R518
250. 250. Bartfai T, Fisone G, Langel U 1992 Galanin and galanin antagonists: molecular and biochemical perspectives. Trends Pharmacol Sci 13:312-317
251. 251. Leibowitz SF, Kim T 1992 Impact of a galanin antagonist on exogenous galanin and natural patterns of fat ingestion. Brain Res 599:148-152
252. 252. Mitchell V, Habert-Ortoli E, Epelbaum J, Aubert JP, Beauvillain JC 1997 Semiquantitative distribution of galanin-receptor (GALR1) mRNA-containing cells in the male rat hypothalamus. Neuroendocrinology 66:160-172
253. 253. Howard AD, Tan C, Shiao L-L, Palyha OC, McKee KK, Weinberg DH, Feighner SD, Cascieri MA, Smith RG, Van der Ploeg LH, Sullivan KA 1997 Molecular cloning and characterization of a new receptor for galanin. FEBS Lett 405:285-290
254. 254. Akabayashi A, Koenig JI, Watanabe Y, Alexander JT, Leibowitz SF 1994 Galanin-containing neurons in the paraventricular nucleus: a neurochemical marker for fat ingestion and body weight gain. Proc Natl Acad Sci USA 91:10375-10379
255. 255. Smith BK, York DA, Bray GA 1994 Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity. Peptides 15:1267-1272
256. 256. Schwartz MW, Sipols AJ, Grubin CE, Baskin DG 1993 Differential effect of fasting on hypothalamic expression of genes encoding neuropeptide Y, galanin, and glutamic acid decarboxylase. Brain Res Bull 31:361-367
257. 257. Beck B, Burlet A, Nicolas JP, Burlet C 1993 Galanin in the hypothalamus of fed and fasted lean and obese Zucker rats. Brain Res 623:124-130
258. 258. Brady LS, Smith MA, Gold PW, Herkenham M 1990 Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 52:441-447
259. 259. Jhanwar-Uniyal M, Chua Jr SC 1993 Critical effects of aging and nutritional state on hypothalamic neuropeptide Y and galanin gene expression in lean and genetically obese Zucker rats. Brain Res Mol Brain Res 19:195-202
260. 260. Morley JE, Levine AS, Yim GK, Lowy MT 1983 Opioid modulation of appetite. Neurosci Biobehav Rev 7:281-305
261. 261. Levine AS, Billington CJ 1989 Opioids: are they regulators of feeding? Ann NY Acad Sci 575:209-219
262. 262. Lambert PD, Wilding JP, al-Dokhayel AA, Gilbey SG, Bloom SR 1993 The effect of central blockade of kappa-opioid receptors on neuropeptide Y-induced feeding in the rat. Brain Res 629:146-148
263. 263. Cole JL, Leventhal L, Pasternak GW, Bowen WD, Bodnar RJ 1995 Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats. Brain Res 678:168-176
264. 264. Millan MJ, Morris BJ 1988 Long-term blockade of mu-opioid receptors suggests a role in control of ingestive behaviour, body weight and core temperature in the rat. Brain Res 450:247-258
265. 265. Lambert PD, Wilding JP, al-Dokhayal AA, Gilbey SG, Ghatei MA, Bloom SR 1994 Nalaxone-induced anorexia increases neuropeptide Y concentrations in the dorsomedial hypothalamus: evidence for neuropeptide Y-opioid interactions in the control of food intake. Peptides 15:657-660
266. 266. Lambert PD, Wilding JP, al-Dokhayal AA, Bohuon C, Comoy E, Gilbey SG, Bloom SR 1993 A role for neuropeptide-Y, dynorphin, and noradrenalin in the central control of food intake after food-deprivation. Endocrinology 133:29-32
267. 267. Bergendahl M, Wiemann JN, Clifton DK, Huhtaniemi I, Steiner RA 1992 Short-term starvation decreases POMC mRNA but does not alter GnRH mRNA in the brain of adult male rats. Neuroendocrinology 56:913-920
268. 268. Garcia de Yebenes E, Li S, Fournier A, St-Pierre S, Pelletier G 1995 Regulation of proopiomelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus. Brain Res 674:112-116
269. 269. Morley JE, Levine AS, Kneip J 1981 Muscimol induced feeding: a model to study the hypothalamic regulation of appetite. Life Sci 29:1213-1218
270. 270. Vaughan JM, Fischer WH, Hoeger C, Rivier J, Vale W 1989 Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology 125:1660-1665
271. 271. Skofitsch G, Jacobowitz DM, Zamir N 1985 Immunohistochemical localization of a melanin concentrating hormone-like peptide in the rat brain. Brain Res Bull 15:635-649
272. 272. Bittencourt JC, Presse F, Arias C, Peto C, Vaughan J, Nahon JL, Vale W, Sawchenko PE 1992 The melanin-concentrating hormone system of the rat brain: an immuno-and hybridization histochemical characterization. J Comp Neurol 319:218-245
273. 273. Parkes D, Vale W 1992 Secretion of melanin-concentrating hormone and neuropeptide-E1 from cultured rat hypothalamic cells. Endocrinology 131:1826-1831
274. 274. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek R, Kanarek R, Maratos-Flier E 1996 A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380:243-247
275. 275. Jezova D, Bartanusz V, Westergren I, Johansson BB, Rivier J, Vale W, Rivier C 1992 Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrier. Endocrinology 130: 1024-1029
276. 276. Presse F, Sorokovsky I, Max JP, Nicolaidis S, Nahon JL 1996 Melanin-concentrating hormone is a potent anorectic peptide regulated by food-deprivation and glucopenia in the rat. Neuroscience 71:735-745
277. 277. Max JP, Nahon JL, Burlet A, Nicolas JP, Burlet C 1993 Rat feeding behavior is not mediated by central injections of MCH. Ann Endocrinol 54:26
278. 278. Rossi M, Choi SJ, O'Shea D, Miyoshi T, Ghatei MA, Bloom SR 1997 Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology 138:351-355
279. 279. Griffond B, Deray A, Nguyen NU, Colard C, Fellmann D 1995 The synthesis of melanin-concentrating hormone is stimulated by ventromedial hypothalamic lesions in the rat lateral hypothalamus: a time-course study. Neuropeptides 28:267-275
280. 280. Deray A, Griffond B, Colard C, Jacquemard C, Bugnon C, Fellmann D 1994 Activation of the rat melanin-concentrating hormone neurons by ventromedial hypothalamic lesions. Neuropeptides 27: 185-194
281. 281. Stanley BG, Willett III VL, Donias HW, Ha LH, Spears LC 1993 The lateral hypothalamus: a primary site mediating excitatory amino acid-elicited eating. Brain Res 630:41-49
282. 282. Stanley BG, Ha LH, Spears LC, Dee II MG 1993 Lateral hypothalamic injections of glutamate, kainic acid, D,L-α-amino-3-hydroxy-5-methyl-isoxazole propionic acid or N-methyl-D-aspartic acid rapidly elicit intense transient eating in rats. Brain Res 613: 88-95
283. 283. Horvath TL, Naftolin F, Leranth C 1992 GABAergic and catecholaminergic innervation of mediobasal hypothalamic beta-endorphin cells projecting to the medial preoptic area. Neuroscience 51:391-399
284. 284. Blasquez C, Jegou S, Feuilloley M, Rosier A, Vandesande F, Vaudry H 1994 Visualization of gamma-aminobutyric acid A receptors on proopiomelanocortin-producing neurons in the rat hypothalamus. Endocrinology 135:2759-2764
285. 285. Jegou S, Blasquez C, Delbende C, Bunel DT, Vaudry H 1993 Regulation of a-melanocyte-stimulating hormone release from hypothalamic neurons. Ann NY Acad Sci 680:260-278
286. 286. Lambert N, Grover L 1995 The mechanism of biphasic GABA responses. Science 269:928-929
287. 287. Staley KJ, Soldo BL, Proctor WR 1995 Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors. Science 269:977-981
288. 288. De Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett II FS, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliff JG 1998 The hypocritins: hypothalamic-specific peptide with neuroexicitatory activity. Proc Natl Acad Sci USA 95:322-327
289. 289. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M 1998 Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585
290. 290. Trivedi P, Yu H, MacNeil D, Van der Ploeg LHT, Guan X-M 1998 Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438:71-75
291. 291. Horvath TL, Diano S, van den Pol AN, Hypocretin (orexin)-containing neurons make synaptic contact with arcuate nucleus NPY and POMC-producing cells that express leptin receptors in rodents and primates: novel hypothalamic circuit involved in energy homeostasis. Program of the 28th Annual Meeting of the Society for Neuroscience, Los Angeles, CA, 1998, vol 24:12 (Abstract)
292. 292. Horvath TL, Diano S, van den Pol AN 1999 Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in the metabolic and endocrine regulation. J Neurosci 19:1072-1087
293. 293. Erickson JC, Clegg KE, Palmister RD 1996 Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415-421
294. 294. Erickson JC, Hollopeter G, Palmiter RD 1996 Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274:1704-1707
295. 295. Vale W, Spiess J, Rivier C, Rivier J 1981 Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corricotropin and beta-endorphin. Science 213:1394-1397
296. 296. Antoni FA 1986 Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 7:351-378
297. 297. Jones MT, Gillham B 1988 Factors involved in the regulation of adrenocorticotropic hormone/beta-lipotropic hormone. Physiol Rev 68:743-818
298. 298. Dunn AJ, Berridge CW 1990 Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev 15:71-100
299. 299. Britton DR, Koob GF, Rivier J, Vale W 1982 Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci 31:363-367
300. 300. Morley JE, Levine AS 1982 Corticotrophin releasing factor, grooming and ingestive behavior. Life Sci 31:1459-1464
301. 301. Krahn DD, Gosnell B A, Levine AS, Morley JE, Localization of the effects of corticotropin-releasing factor on feeding. Program of the 14th Annual Meeting of the Society for Neuroscience, 1984, vol 10:302 (Abstract)
302. 302. Perrin MH, Donaldson CJ, Chen R, Lewis KA, Vale WW 1993 Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 133:3058-3061
303. 303. Chang CP, Pearse II RV, O'Connell S, Rosenfeld MG 1993 Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11:1187-1195
304. 304. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, Vale W 1994 Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 91:8777-8781
305. 305. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, Oltersdorf T 1995 Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92:836-840
306. 306. Heinrichs SC, Menzaghi F, Pich EM, Hauger RL, Koob GF 1993 Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res 611:18-24
307. 307. Kwak SP, Young EA, Morano I, Watson SJ, Akil H 1992 Diurnal corticotropin-releasing hormone mRNA variation in the hypothalamus exhibits a rhythm distinct from that of plasma corticosterone. Neuroendocrinology 55:74-83
308. 308. Kwak SP, Morano MI, Young EA, Watson SJ, Akil H 1993 Diurnal CRH mRNA rhythm in the hypothalamus: decreased expression in the evening is not dependent on endogenous glucocorticoids. Neuroendocrinology 57:96-105
309. 309. Rohner-Jeanrenaud F 1995 A neuroendocrine reappraisal of the dual-centre hypothesis: its implications for obesity and insulin resistance. In J Obes Relat Metab Disord 19:517-534
310. 310. Rohner-Jeanrenaud F, Walker CD, Greco-Perotto R, Jeanrenaud B 1989 Central corticotropin-releasing factor administration prevents the excessive body weight gain of genetically obese (fa/fa) rats. Endocrinology 124:733-739
311. 311. Kato H, Saito M, Suda M 1980 Effect of starvation on the circadian adrenocortical rhythm in rats. Endocrinology 106:918-921
312. 312. Stanley BG, Lanthier D, Chin AS, Leibowitz SF 1989 Suppression of neuropeptide Y-elicited eating by adrenalectomy or hypophysectomy: reversal with corticosterone. Brain Res 501:32-36
313. 313. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W 1995 Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378:287-292
314. 314. Spina M, Merlo-Pich E, Chan RK, Basso AM, Rivier J, Vale W, Koob GF 1996 Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273:1561-1564
315. 315. Heinrichs SC, Lapsansky J, Behan DP, Chan RK, Sawchenko PE, Lorang M, Ling N, Vale WW, De Souza EB 1996 Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal. Proc Natl Acad Sci USA 93:15475-15480
316. 316. Carraway R, Leeman SE 1973 The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem 248: 6854-6861
317. 317. Carraway R, Leeman SE 1975 The aminoacid sequence of a hypothalamic peptide, neurotensin. J Biol Chem 250:1907-1911
318. 318. Hawkins MF 1986 Central nervous system neurotensin and feeding. Physiol Behav 36:1-8
319. 319. Hökfelt T, Everitt BJ, Theodorsson-Norheim E, Goldstein M 1984 Occurrence of neurotensin-like immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons. J Comp Neurol 222:543-559
320. 320. Ibata Y, Kawakami F, Fukui K, Obata-Tsuto HL, Tanaka M, Kubo T, Okamura H, Morimoto N, Yanaihara C, Yanaihara N 1984 Light and electron microscopic immunocytochemistry of neurotensin-like immunoreactive neurons in the rat hypothalamus. Brain Res 302:221-230
321. 321. Alexander MJ, Miller MA, Dorsa DM, Bullock BP, Melloni Jr RH, Dobner PR, Leeman SE 1989 Distribution of neurotensin/neuromedin N mRNA in rat forebrain: unexpected abundance in hippocampus and subiculum. Proc Natl Acad Sci USA 86:5202-5206
322. 322. Stanley BG, Hoebel BG, Leibowitz SF 1983 Neurotensin: effects of hypothalamic and intravenous injections on eating and drinking in rats. Peptides 4:493-500
323. 323. Stanley BG, Eppel N, Hoebel BG 1982 Neurotensin-injected into the paraventricular hypothalamus suppresses feeding in rats. Ann NY Acad Sci 400:425
324. 324. Wilding JP, Gilbey SG, Bailey CJ, Batt RA, Williams G, Ghatei MA, Bloom SR 1993 Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 132: 1939-1944
325. 325. Beck B, Nicolas JP, Burlet C 1995 Neurotensin decreases with fasting in the ventromedian nucleus of obese Zucker rats. Metabolism 44:972-975
326. 326. Rovere C, Viale A, Nahon J, Kitabgi P 1996 Impaired processing of brain proneurotensin and promelanin-concentrating hormone in obese fat/fat mice. Endocrinology 137:2954-2958
327. 327. Shimizu I, Hirota C, Obhboshi C, Shima K 1987 Identification and characterization of glucagon-like peptide 1 7-36 amide binding site in the rat brain and lung. FEBS Lett 241:209-212
328. 328. Fehmann HC, Goke R, Goke B 1995 Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev 16:390-410
329. 329. Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C 1997 Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brain stem. Neuroscience 77:257-270
330. 330. Kreymann B, Ghatei MA, Burnet P, Williams G, Kanse S, Diani AR, Bloom SR 1989 Characterization of glucagon-like peptide-1-(7-36)amide in the hypothalamus. Brain Res 502:325-331
331. 331. Shughrue PJ, Lane MV, Merchenthaler I 1996 Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. Endocrinology 137:5159-5162
332. 332. Jin SL, Han VK, Simmons JG, Towle AC, Lauder JM, Lund PK 1988 Distribution of glucagon-like peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study. J Comp Neurol 271:519-532
333. 333. Alvarez E, Roncero I, Chowen JA, Thorens B, Blazquez E 1996 Expression of the glucagon-like peptide-1 receptor gene in rat brain. J Neurochem 66:920-927
334. 2 in the central control of feeding behavior. Digestion 54:360-361
335. 335. Turton MD, O'Shea D, Gunn IN, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR 1996 A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69-72
336. 336. Tang-Christensen M, Larsen PJ, Goke R, Fink-Jensen A, Jessop DS, Moller M, Sheikh SP 1996 Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol 271:R848-R856
337. 337. Eng J 1992 Exendin peptides. Mt Sinai J Med 59:147-149
338. 338. van Dijk G, Thiele TE, Seeley RJ, Woods SC, Bernstein IL 1997 Glucagon-like peptide-1 and satiety. Nature 385:214
339. 339. McMahon LR, Wellman PJ, PVN infusion of GLP-1 (7-36) amide suppresses feeding and drinking but does not induce conditioned taste aversion or alter locomotion in rats. Program of the 27th Annual Meeting of the Society for Neuroscience, New Orleans, LA, 1997, vol 23:1076 (Abstract)
340. 340. Goldstone AP, Mercer JG, Gunn I, Moar KM, Edwards CM, Rossi M, Howard JK, Rasheed S, Turton MD, Small C, Heath MM, O'Shea D, Steere J, Meeran K, Ghatei MA, Hoggard N, Bloom SR 1997 Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents. FEBS Lett 415:134-138
341. 341. Scrocchi LA, Brown TJ, MacLusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ 1996 Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2:1254-1258
342. 342. Yen TT, Gill AM, Frigeri LG, Barsh GS, Wolff GL 1994 Obesity, diabetes, and neoplasia in yellow A(vy)/ - mice: ectopic expression of the agouti gene. FASEB J 8:479-488
343. 343. Siracusa LD 1994 The agouti gene: turned on to yellow. Trends Genet 10:423-428
344. 344. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD 1997 Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168
345. 345. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO, Cone RD 1994 Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371:799-802
346. 346. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F 1997 Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141
347. 347. Jacobowitz DM, O'Donohue TL 1978 α-Melanocyte stimulating hormone: immunohistochemical identification and mapping in neurons of the rat brain. Proc Natl Acad Sci USA 75:6300-6304
348. 348. Joseph SA, Pilcher WH, Bennet-Clarke C 1983 Immunocytochemical localization of ACTH perikarya in nucleus tractus solitarius: evidence for a second opiocortin neuronal system. Neurosci Lett 38:221-225
349. 349. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD 1992 The cloning of a family of genes that encode the melanocortin receptors. Science 257:1248-1251
350. 350. Gantz I, Konda Y, Tashiro T, Shimoto Y, Miwa H, Munzert G, Watson SL Del Valle J, Yamada T 1993 Molecular cloning of a novel melanocortin receptor. J Biol Chem 268:8246-8250
351. 351. Roselli-Rehfuss L, Mountjoy KG, Robbins LS, Mortrud MT, Low MJ, Tatro JB, Entwistle ML, Simerly RB, Cone RD 1993 Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 90:8856-8860
352. 352. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, Del Valle J, Yamada T 1993 Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 268:15174-15179
353. 353. Griffon N, Mignon V, Facchinetti P, Diaz J, Schwartz JC, Sokoloff P 1994 Molecular cloning and characterization of the rat fifth melanocortin receptor. Biochem Biophys Res Commun 200:1007-1014
354. 354. Gantz I, Shimoto Y, Konda Y, Miwa H, Dickinson CJ, Yamada T 1994 Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem Biophys Res Commun 200:1214-1220
355. 355. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD 1994 Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8:1298-1308
356. 356. Tatro JB 1990 Melanotropin receptors in the brain are differentially distributed and recognize both corticotropin and α-melanocyte stimulating hormone. Brain Res 536:124-132
357. 357. Schioth HB, Mutulis F, Muceniece R, Prusis P, Wikberg JE 1998 Discovery of novel melanocortin4 receptor selective MSH analogues. Br J Pharmacol 124:75-82
358. 358. Kask A, Mutulis F, Muceniece R, Pahkla R, Mutule I, Wikberg JE, Rago L, Schioth HB 1998 Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): evaluation in vitro and in vivo. Endocrinology 139:5006-5014
359. 359. Kask A, Rago L, Mutulis F, Pahkla R, Wikberg JE, Schioth HB 1998 Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats. Biochem Biophys Res Commun 245:90-93
360. 360. Skuladottir GV, Jonsson L, Skarpedinsson JO, Mutulis F, Muceniece R, Raine A, Mutule I, Helgason J, Prusis P, Wikberg JE, Schioth HB 1999 Long-term orexigenic effect of a novel melanocortin 4 receptor selective antagonist. Br J Pharmacol 126:27-34
361. 361. Kask A, Rägo L, Korrovits P, Wikberg JE, Schioth HB 1998 Evidence that orexigenic effects of melanocortin 4 receptor antagonists HS014 are mediated by neuropeptide Y. Biochem Biophys Res Commun 248:245-249
362. 362. Cheung CC, Clifton DK, Steiner RA 1997 Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138:4489-4492
363. 363. Thornton JE, Cheung CC, Clifton DK, Steiner RA 1997 Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 138:5063-5066
364. 364. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG 1997 Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46:2119-2123
365. 365. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, Schwartz MW 1997 Melanocortin receptors in leptin effects. Nature 390:349
366. 366. Boston BA, Blaydon KM, Varnerin J, Cone RD 1997 Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 278:1641-1644
367. 367. Broberger C, Johansen J, Johansson C, Schalling M, Hökfelt T 1998 The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 95:15043-15048
368. 368. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P 1996 Localization of leptin receptor mRNA and the long form splice variant (Ob/Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 387:113-116
369. 369. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Morgan PJ, Trayhurn P 1996 Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 8:733-735
370. 370. Gloaguen I, Costa P, Demartis A, Lazzaro D, Di Marco A, Graziani R, Paonessa G, Chen F, Rosenblum CI, Van der Ploeg LH, Cortese R, Ciliberto G, Laufer R 1997 Ciliary neurotropic factor corrects obesity and diabetes associated with leptin deficiency and resistance. Proc Natl Acad Sci USA 94:6456-6461
371. 371. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM 1996 Leptin enters the brain by a saturable system independent of insulin. Peptides 17:305-311
372. 372. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte Jr D, Woods SC, Seeley RJ, Weigle DS 1996 Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45:531-535
373. 373. Vasselli JR, Chu K, Maggio CA, Differential effects of subcutaneous injections of leptin on feeding and body weight in genetically obese, lean and Sprague-Dawley rats. Program of the Annual Meeting of the Society for the Study of Ingestive Behavior, Baltimore, MD, 1997, p 40
374. 374. Chen G, Koyama K, Yuan X, Lee Y, Zhou YT, O'Doherty R, Newgard CB, Unger RH 1996 Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc Natl Acad Sci USA 93:14795-14799
375. 375. Muzzin P, Eisensmith RC, Copeland KC, Woo SL 1996 Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc Natl Acad Sci USA 93:14804-14808
376. 376. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM 1997 Physiological response to long-term peripheral and central infusion in lean and obese mice. Proc Natl Head Sci USA 94:8878-8883
377. 377. Woods AJ, Stock MJ 1996 Leptin activation in hypothalamus. Nature 381:745
378. 378. Van Dijk G, Thiele TE, Donahey JC, Campfield LA, Smith FJ, Burn P, Bernstein IL, Woods SC, Seeley RJ 1996 Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain. Am J Physiol 271:R1096-1100
379. 379. Håkansson ML, Brown H, Ghilardi N, Skoda RC, Meister B 1998 Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 18:559-572
380. 380. Håkansson M-L, Hulting A-L, Meister B 1996 Expression of leptin receptor mRNA in the hypothalamic arcuate nucleus-relationship with NPY neurones. Neuroreport 7:3087-3092
381. 381. Huang XF, Koutcherou I, Lin S, Wang HQ, Storlien L 1996 Localization of leptin receptor mRNA expression in mouse brain. Neuroreport 7:2635-2638
382. 382. Lee J, Morris MJ 1998 Modulation of neuropeptide Y overflow by leptin in the rat hypothalamus, cerebral cortex and medulla. Neuroreport 9:1575-1580
383. 383. Beck B, Kozak R, Stricker-Krongrad A, Burlet C 1998 Neuropeptide Y release in the paraventricular nucleus of Long-Evans rat treated with leptin. Biochem Biophys Res Commun 242:636-639
384. 384. Smith FJ, Campfield LA, Moschera JA, Bailon PS, Burn P 1996 Feeding inhibition by neuropeptide Y. Nature 382:307
385. 385. Sahu A 1998 Leptin decreases food intake induced by galanin (GAL), melanin concentrating hormone (MCH) and neuropeptide Y (NPY) in the rat. Program of the 80th Annual Meeting of The Endocrine Society, New Orleans, LA, 1998 (Abstract P3-253), p 439
386. 386. Mercer J, Moar KM, Hoggard N 1998 Localization of leptin receptor (Ob-R) messenger ribonucleic acid in the rodent brain. Endocrinology 139:29-34
387. 387. Sahu A 1998 Evidence suggesting that galanin (GAL), melanin-concentrating hormone (MCH), neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y (NPY) are targets of leptin signaling in the hypothalamus. Endocrinology 139:795-798
388. 388. Satoh N, Ogawa Y, Katsuura G, Tsuiji T, Masuzaki H, Hiroaka J, Kazaki T, Tamoki M, Hyashi M, Yoshimasa Y, Nishin S, Nosoda K, Nakao K 1997 Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats. Endocrinology 138:947-954
389. 389. Armstrong S 1980 A chronometric approach to the study of feeding behavior. Neurosci Behav Rev 4:27-53
390. 390. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J 1995 Transient increase in obese gene expression after food intake or insulin administration. Nature 377:527-529
391. 391. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS 1996 Role of leptin in the neuroendocrine response to fasting. Nature 382:250-252
392. 392. Baskin DG, Seeley RJ, Kuijper JL, Lok S, Weigle DS, Erickson JC, Palmiter RD, Schwartz MW 1998 Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting. Diabetes 47: 538-543
393. 393. Bennett PA, Lindell K, Karlsson C, Robinson IC, Carlsson LM, Carlsson B 1998 Differential expression and regulation of leptin receptor isoforms in the rat brain: effects of fasting and oestrogen. Neuroendocrinology 67:29-36
394. 394. Lonnqvist F, Arner P, Nordfors L, Schalling M 1995 Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1:950-953
395. 395. Hamilton BS, Paglia D, Kwan AY, Deitel M 1995 Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1:953-956
396. 396. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM 1995 Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161
397. 397. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N EngI J Med 334:292-295
398. 398. Kolaczynski JW, Ohannesian JP, Considine RV, Marco CC, Caro JF 1996 Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab 81:4162-4165
399. 399. Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, Marco C, Caro JF 1996 Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 97:1344-1347
400. 400. Sinha MK, Sturis J, Ohannesian J, Magosin S, Stephens T, Heiman ML, Polonsky KS, Caro JF 1996 Ultradian oscillations of leptin secretion in humans. Biochem Biophys Res Commun 228: 733-738
401. 401. Licinio J, Mantzoros C, Negrao AB, Cizza G, Wong ML, Bongiorno PB, Chrousos GP, Karp B, Allen C, Flier JS, Gold PW 1997 Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med 3:575-579
402. 402. Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, Ma Z, Vignati L, Bowsher R, Herzog D, Klibanski A 1996 Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 81:3861-3863
403. 403. Spanswick D, Smith MA, Groppi VE, Logan SD, Ashford MLJ 1997 Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 390:521-525
404. 404. Glaum SR, Kara M, Bindokas VP, Lee CC, Polonsky KS, Bell GI, Miller RJ 1996 Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus. Mol Pharmacol 50: 230-235
405. 405. Diano S, Kalra SP, Horvath TL 1998 Leptin receptor immunoreactivity is associated with the Golgi apparatus of hypothalamic neurons and glial cells. J Neuroendocrinol 10:647-650
406. 406. Tartaglia LA 1997 The leptin receptor. J Biol Chem 272:6093-6096
407. 407. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC 1996 Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 93:6231-6235
408. 408. Vaisse C, Halaas JL, Horvath CM, Darnell Jr JE, Stoffel M, Friedman J 1996 Leptin activation of STAT3 in the hypothalamus of wild type and ob/ob but not db/db mice. Nat Genet 14:95-97
409. 409. McCowen K, Chow JC, Smith RJ 1998 Leptin signaling in the hypothalamus of normal rats in vivo. Endocrinology 139:4442-4447
410. 410. Watanabe S, Arai KI 1996 Roles of the JAK-STAT system in signal transduction via cytokine. Curr Opin Genet Dev 6:587-596
411. 411. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ 1997 A family of cytokine-inducible inhibitors of signalling. Nature 387:917-921
412. 412. Bjorback C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS 1998 Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1:619-625